BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10579136)

  • 1. Hypertrophic cardiomyopathy with mid-ventricular obstruction and splenic infarction associated with paroxysmal atrial fibrillation: a case report.
    Tokuyasu K; Hara Y; Matsumoto Y; Hashida H; Ikeda S; Ohtsuka T; Hiasa G; Kitami Y; Shigematsu Y; Hamada M; Hiwada K
    J Cardiol; 1999 Nov; 34(5):273-7. PubMed ID: 10579136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of percutaneous transluminal septal myocardial ablation on refractory paroxysmal atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy.
    Hosokawa Y; Takano H; Ohno T; Takayama M; Takano T
    Angiology; 2008; 59(3):329-34. PubMed ID: 18388103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemolytic anemia in a patient with hypertrophic obstructive cardiomyopathy.
    Kubo T; Kitaoka H; Terauchi Y; Tamura S; Okawa M; Yamasaki N; Yabe T; Doi YL
    J Cardiol; 2010 Jan; 55(1):125-9. PubMed ID: 20122559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic agent cibenzoline attenuates latent obstruction in the left ventricular outflow tract of hypertrophic cardiomyopathy.
    Nomura T; Kojima A; Urakabe Y; Enomoto-Uemura S; Nishikawa S; Keira N; Matsubara H; Tatsumi T
    Int J Cardiol; 2011 May; 148(3):359-61. PubMed ID: 20888654
    [No Abstract]   [Full Text] [Related]  

  • 5. An early systolic sound associated with midventricular obstruction in a patient with hypertrophic cardiomyopathy.
    Ohtsuka T; Hamada M; Hara Y; Kuwahara T; Kodama K; Shigematsu Y; Iwata T; Hiwada K
    Jpn Circ J; 1998 May; 62(5):385-8. PubMed ID: 9626909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paroxysmal atrial fibrillation as a cause of potentially lethal ventricular arrhythmia with myocardial ischemia in hypertrophic cardiomyopathy--a case report.
    Suzuki M; Hirayama T; Marumoto K; Okayama H; Iwata T
    Angiology; 1998 Aug; 49(8):653-7. PubMed ID: 9717897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of hypertrophic cardiomyopathy with right ventricular outflow obstruction manifested during three-year follow-up study].
    Satoh R; Okada T; Oimatsu H; Sawai K; Ogawa T; Tuchida A
    Kokyu To Junkan; 1990 Sep; 38(9):913-7. PubMed ID: 2236965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Splenic infarction as a complication of atrial fibrillation].
    Muñoz Ruiz AI; Guerrero Vega E; García Flores S; de Tena-Dávila Ruiz M; Marcos Sánchez F; Durán Pérez-Navarro A
    Rev Esp Enferm Dig; 2003 Jan; 95(1):66-7. PubMed ID: 12760732
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of cibenzoline for chest oppression and ventricular arrhythmia during effort and alcohol consumption in a patient with hypertrophic obstructive cardiomyopathy: a case report].
    Sasayama T; Horimoto M; Takeda T; Takenaka T; Inoue H; Igarashi K; Akino M; Kikuchi K
    J Cardiol; 2000 Jun; 35(6):445-50. PubMed ID: 10884982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of atrial fibrillation surgery in patients with hypertrophic cardiomyopathy.
    Chen MS; McCarthy PM; Lever HM; Smedira NG; Lytle BL
    Am J Cardiol; 2004 Feb; 93(3):373-5. PubMed ID: 14759397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Left atrial function and left atrial appendage flow velocity in hypertrophic cardiomyopathy: comparison of patients with and without paroxysmal atrial fibrillation].
    Akasaka K; Kawashima E; Shiokoshi T; Ishii Y; Hasebe N; Kikuchi K
    J Cardiol; 1998 Jul; 32(1):31-8. PubMed ID: 9739515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.
    Hiasa G; Hamada M; Shigematsu Y; Hara Y; Ohtsuka T; Ogimoto A; Saeki H; Suzuki J; Matsunaka T; Hamada H; Okura T; Hiwada K
    Circ J; 2002 Dec; 66(12):1173-5. PubMed ID: 12499627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mid-ventricular hypertrophic obstructive cardiomyopathy presenting with acute myocardial infarction.
    Sato Y; Matsumoto N; Matsuo S; Yoda S; Kunimoto S; Saito S
    Tex Heart Inst J; 2007; 34(4):475-8. PubMed ID: 18172535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of cibenzoline on left ventricular pressure gradient with sigmoid septum.
    Konishi C; Shiraishi J; Muraguchi N; Ohtsuki K; Inoue M; Tatsumi T; Azuma A; Matsubara H
    Circ J; 2004 Oct; 68(10):968-71. PubMed ID: 15459474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V; Ickrath O; Seipel L
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beneficial effect of cibenzoline in a patient with hypertrophic obstructive cardiomyopathy complicated with idiopathic interstitial pneumonia].
    Saito M; Hara Y; Shigematsu Y; Ohtsuka T; Saeki H; Ogimoto A; Yokoyama A; Hamada M
    Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):62-4. PubMed ID: 12649850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of mid-ventricular obstruction of hypertrophic cardiomyopathy by real-time two-dimensional Doppler flow imaging: a case report].
    Matsuno Y; Izumi S; Murakami R; Murakami Y; Kobayashi S; Morioka S; Moriyama K
    J Cardiol; 1989 Jun; 19(2):627-35. PubMed ID: 2636639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of atrial fibrillation in the natural history of hypertrophic cardiomyopathy].
    Albanesi Filho FM; Girardi JM; Castier MB; Ginefra P
    Arq Bras Cardiol; 1994 May; 62(5):337-41. PubMed ID: 7998866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.